About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.95 (-1.39%)
SVRA NASDAQ Savara Inc
Savara Inc share price
Atividade de preço de SVRA
Último preço
$ 4,950
Variação (24h)
-0,07 USD (1,39%)
Volume
1.73M
Volume (média 4 sem.)
-
Abertura
$ 5,05
Variação do dia
$ 4,92 - $ 5,14
Fechamento anterior
$ 5,02
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
SVRA price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals